pharmaceutical investing Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights
NEVGOLD ANNOUNCES MINERAL RESOURCE: ANTIMONY OF 29,600 TONNES MEASURED & INDICATED AND 48,100 TONNES INFERRED ; 100% OXIDE GOLD OF 181,400 OZS MEASURED & INDICATED AND 1,203,500 OZS INFERRED; STRATEGIC U.S. ANTIMONY RESOURCE
SAGA Metals Reports Assays from R-0047 to R-0049 with Intercepts Including 53.72% Fe2O3, 7.32% TiO2, 0.431% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
